Brought to you by 
Proligo buys Genset's oligo division
09 Sep 2020
Executive Summary
German specialty chemicals company Degussa AG will buy Genset SA's (French genomics company) Genset Oligos division for about $21.8mm (Euro25mm) and merge it into Proligo, its own oligonucleotides subsidiary in Boulder, Colorado.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Antisense, Oligonucleotides
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Proligo buys Genset's oligo division
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice